Burkholderia pseudomallei capsular polysaccharide conjugates provide protection against acute melioidosis

Andrew E Scott1, Mary N Burtnick2, Margaret G M Stokes3

  • 1Defence Science and Technology Laboratory, Porton Down, Salisbury, United Kingdom aescott2@dstl.gov.uk.

Insights

Developing a vaccine against melioidosis is crucial. Researchers found that a capsular polysaccharide (CPS) glycoconjugate, especially when combined with recombinant LolC, effectively protected mice against Burkholderia pseudomallei challenge.

Area of Science:

  • Microbiology and Immunology
  • Vaccine Development
  • Bacterial Pathogenesis

Background:

  • Melioidosis, caused by Burkholderia pseudomallei, is a severe and often fatal emerging infectious disease with no current vaccine.
  • B. pseudomallei is a CDC tier 1 select agent with potential for malicious use, increasing the need for effective countermeasures.
  • Current diagnosis and treatment of melioidosis are challenging, highlighting the urgency for preventative strategies.

Purpose of the Study:

  • To evaluate the immunogenicity and protective efficacy of glycoconjugates derived from B. pseudomallei capsular polysaccharide (CPS) and O-polysaccharide (OPS) antigens.
  • To determine if combining CPS-based vaccines with recombinant B. pseudomallei LolC enhances protection against melioidosis.
  • To identify promising candidates for a subunit vaccine against B. pseudomallei infection.

Main Methods:

  • Isolation and covalent linkage of type A O-polysaccharide (OPS) and manno-heptose capsular polysaccharide (CPS) antigens to carrier proteins, forming OPS2B1 and CPS2B1 conjugates.
  • Immunization of BALB/c mice with OPS2B1 and CPS2B1 glycoconjugates to assess IgG responses.
  • Challenge studies in mice using intraperitoneal injection of B. pseudomallei to evaluate protection conferred by CPS2B1, individually and in combination with recombinant B. pseudomallei LolC.

Main Results:

  • Both OPS2B1 and CPS2B1 elicited high-titer IgG responses in mice.
  • Only immunization with CPS2B1 provided protection against lethal B. pseudomallei challenge.
  • A combination of CPS2B1 and recombinant B. pseudomallei LolC resulted in significantly higher survival rates compared to individual immunizations.

Conclusions:

  • CPS-based glycoconjugates are promising candidates for developing subunit vaccines against melioidosis.
  • Combining CPS-based vaccines with recombinant LolC may offer enhanced protective immunity against B. pseudomallei.
  • Further research into CPS-based glycoconjugates holds potential for effective melioidosis immunization strategies.

Related Concept Videos

Defense Against Bacterial Pathogens01:31

Defense Against Bacterial Pathogens

The human immune system is a complex network of cells, tissues, and organs that work together to defend the body against bacterial infections. It consists of various immune cells, each playing a specific role in the defense mechanism.
Phagocytes
Phagocytes are the frontline soldiers of the immune system. They include neutrophils and macrophages. Neutrophils are the most abundant type of white blood cell and are quickly mobilized to the site of infection. Macrophages are larger cells that patrol...
3.0K
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within...
90
Bacterial Meningitis II: Pathophysiology01:26

Bacterial Meningitis II: Pathophysiology

Bacterial meningitis typically begins when pathogens such as Neisseria meningitidis and Streptococcus pneumoniae colonize the nasopharynx and invade the bloodstream. This process is facilitated by bacterial virulence factors, such as polysaccharide capsules, which resist phagocytosis and complement-mediated killing. Less commonly, bacteria reach the central nervous system via contiguous spread from infections like otitis media or sinusitis, through congenital or acquired dural defects, or...
16
Inhibitors of Gram-positive Cell Wall Synthesis01:23

Inhibitors of Gram-positive Cell Wall Synthesis

Bacterial cell walls are typically rigid structures composed mainly of peptidoglycan, a mesh-like polymer that provides mechanical strength and maintains cell shape. The synthesis of peptidoglycan is a crucial process in bacterial growth and serves as a primary target for many antibiotics.Mechanism of Action of Beta-Lactam AntibioticsBeta-lactam antibiotics, such as penicillin, inhibit peptidoglycan synthesis in actively growing cells. These antibiotics share a characteristic four-membered...
181
Regulation of Bacterial Virulence01:28

Regulation of Bacterial Virulence

Pathogenic bacteria employ a range of regulatory mechanisms to modulate the expression of virulence genes in response to environmental and host-derived signals. These mechanisms ensure that virulence factors are expressed only under favorable conditions, thereby optimizing infection and survival strategies.Mechanisms of Virulence RegulationKey regulatory strategies include:Two-Component Systems: These consist of a membrane-bound sensor kinase and a cytoplasmic response regulator. Environmental...
71